"The
Report Nasopharyngitis (Common Cold) - Pipeline Review, H2 2016
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
lobal
Markets Directs, Nasopharyngitis
(Common Cold)
- Pipeline Review, H2 2016, provides an overview of the
Nasopharyngitis (Common Cold) pipeline landscape.
The
report provides comprehensive information on the therapeutics under
development for Nasopharyngitis (Common Cold), complete with analysis
by stage of development, drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type. The report also
covers the descriptive pharmacological action of the therapeutics,
its complete research and development history and latest news and
press releases. Additionally, the report provides an overview of key
players involved in therapeutic development for Nasopharyngitis
(Common Cold) and features dormant and discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Get
the Free Sample copy of this Report @
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Nasopharyngitis (Common Cold)
-
The report reviews pipeline therapeutics for Nasopharyngitis (Common
Cold) by companies and universities/research institutes based on
information derived from company and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which
includes,
product description, descriptive MoA, R&D brief, licensing and
collaboration details & other developmental activities
-
The report reviews key players involved Nasopharyngitis (Common Cold)
therapeutics and enlists all their major and minor projects
-
The report assesses Nasopharyngitis (Common Cold) therapeutics based
on drug target, mechanism of action (MoA), route of administration
(RoA) and molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Nasopharyngitis (Common Cold)
Reasons to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Nasopharyngitis (Common Cold)
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Nasopharyngitis (Common Cold) pipeline depth and focus of Indication
therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table
of Contents
Table
of Contents 2
List
of Tables 4
List
of Figures 4
Introduction
5
Global
Markets Direct Report Coverage 5
Nasopharyngitis
(Common Cold) Overview 6
Therapeutics
Development 7
Pipeline
Products for Nasopharyngitis (Common Cold) - Overview 7
Pipeline
Products for Nasopharyngitis (Common Cold) - Comparative Analysis 8
Nasopharyngitis
(Common Cold) - Therapeutics under Development by Companies 9
Nasopharyngitis
(Common Cold) - Therapeutics under Investigation by
Universities/Institutes 10
Nasopharyngitis
(Common Cold) - Pipeline Products Glance 11
Late
Stage Products 11
Early
Stage Products 12
Nasopharyngitis
(Common Cold) - Products under Development by Companies 13
Nasopharyngitis
(Common Cold) - Products under Investigation by
Universities/Institutes 14
Nasopharyngitis
(Common Cold) - Companies Involved in Therapeutics Development 15
Charleston
Laboratories, Inc. 15
Cocrystal
Pharma, Inc. 16
Orbis
Biosciences Inc 17
Vernalis
Plc 18
Nasopharyngitis
(Common Cold) - Therapeutics Assessment 19
Assessment
by Monotherapy Products 19
Assessment
by Combination Products 20
Assessment
by Target 21
Assessment
by Mechanism of Action 23
Assessment
by Route of Administration 25
Assessment
by Molecule Type 27
Drug
Profiles 29
(levocetirizine
dihydrochloride + montelukast sodium) - Drug Profile 29
Product
Description 29
Mechanism
Of Action 29
R&D
Progress 29
Antibodies
to Target TRIM-21 for Gastrointestinal and Ear Nose Throat Disorders
- Drug Profile 30
Product
Description 30
Mechanism
Of Action 30
R&D
Progress 30
CCP-05
- Drug Profile 31
Product
Description 31
Mechanism
Of Action 31
R&D
Progress 31
CCP-06
- Drug Profile 32
Product
Description 32
Mechanism
Of Action 32
R&D
Progress 32
CCP-07
- Drug Profile 33
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA:
Canada Toll Free: 866-997-4948
No comments:
Post a Comment